ClinicalTrials.gg
RecruitingNCT07371559Updated Jan 28, 2026

Assessment of Food Intake Using Both 3D Scanning Method and a Photographic Method

An observational study in Data Collection, sponsored by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. Recruiting at 1 site in China. Open to participants aged 22 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-28.

Sponsored by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
22 Years to 40 Years
Sex
All
01

Study summary

This project aims to develop a new and more accurate method to assess energy intake in the diet by collaborating with Astravis company in Switzerland, integrating image recognition and intelligent applications, to improve the accuracy of energy assessment in the food, and to explore the application in dietary research.The researchers will recruit 200 volunteers.

Read the detailed description

This study will provide food for the participants, and they will independently choose their preferred food for consumption according to their usual dietary habits. This study will take 3D scanning and photography of the food plates before and after eating to analyze the energy intake by each participant.

02

Conditions studied

  • Data Collection

Browse trials for

Keywords

  • food intake
  • food preference
  • food energy assessment
03

In context

Food Preferences

155 studies on the registry are indexed under Food Preferences; 19 are open to participants now.

This study's planned enrollment of 200 is above the median of 80 across 34 observational studies indexed under Food Preferences.

Browse Food Preferences studies →

Lead sponsor

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences is the lead sponsor of 22 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants are healthy, with no metabolic disorder, 22 - 40 years old

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Recently measured (BMI): normal control group (21.5 ≤ BMI \< 25); Recently measured body mass index (BMI): healthy underweight group (15 \< BMI ≤ 18.5); Must be able to choose the food as requested.

Exclusion criteria

Exclusion Criteria:

Metabolic diseases; Recent weight loss due to various disease causes; Ongoing treatment for weight loss; Eating disorders; Pregnant or lactating women; Infectious diseases such as , Hepatitis; Diabetes mellitus.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Control

    21.5≤BMI\<25, age between 25-40 years old, 100subjects.

  • Superlean

    15\<BMI≤18.5, age between 25-40 years old, 100 subjects.

06

What researchers measure

Primary outcomes

  1. BMI of the volunteers

    The volunteers' BMI is chosen between normal and underweight for easy comparison.

    Time frame: This study will take about 1 year and a half to finish, starting from May 1 2025 to Dec 31 2026.

  2. 3D scanning of the foods chosen by volunteers using a Bodyscan3d smartphone application

    The volunteers will be asked to choose 5 out of 20 dishes in a buffet and 3D scanning of the foods chosen by volunteers will be taken using a Bodyscan3d application.

    Time frame: This study will take about 1 year and a half to finish, starting from May 1 2025 to Dec 31 2026.

  3. Weight and name of each food

    The weight and name of the food selected by the volunteers will be systematically recorded using a digital electronic scale and food record form. This scale and food record form will be employed to ensure accurate measurements of each food item's mass that the volunteers consume throughout the study period and each food item they choose.

    Time frame: This study will take about 1 year and a half to finish, starting from May 1 2025 to Dec 31 2026.

  4. Calories of the food chosen by the volunteers will be evaluated using the Hava smartphone application

    We use another Hava application to evaluate the calories of the food selected by the volunteers and compare with the calories we calculated, with the smaller the difference, the better the Hava assessment.

    Time frame: This study will take about 1 year and a half to finish, starting from May 1 2025 to Dec 31 2026.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2026; primary completion for Dec 2026, 11 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 3, 2025
First posted
Jan 28, 2026
StartEst.
Jan 31, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jan 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07371559
Lead sponsor
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Responsible party
John R. Speakman (Professor, Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences) — Principal investigator
First posted
Jan 28, 2026
Start date
Jan 31, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jan 28, 2026

Study contacts

John Roger Speakman, PhD
Contact
j.speakman@abdn.ac.uk
15810868669
Ying Yu, PhD
Contact
y.yu@siat.ac.cn
18513508048

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion